Name: Oramed Pharmaceuticals Inc (XTAE:ORMP) Dividend History
Creator: GuruFocus
Keywords: XTAE:ORMP dividend, Oramed Pharmaceuticals Inc dividend history, XTAE:ORMP ex-dividend date, XTAE:ORMP yield

Oramed Pharmaceuticals Inc (XTAE:ORMP) pays a dividend yield of 5.81% ($0.25 per share annually). The payout ratio is 0.14. The 5-year dividend growth rate is 0%. Oramed Pharmaceuticals Inc has been paying dividends since 2026.

Below is Oramed Pharmaceuticals Inc's complete dividend history, ex-dividend dates, payout ratio trends, and dividend yield charts.

Dividend started since

2026

Years of Dividend History

5.81% (Trailing)

5.81% (Forward)

Dividend Yield

0.14

Dividend Payout Ratio

Growth Rate (5-Year)

5.81%

Yield on Cost (5-Year)

0.2%

3-Year Share Buyback Ratio

* Special dividend is not included in the calculation of dividend per share and related fields

Dividend Growth

Oramed Pharmaceuticals Inc Dividend History & Ex-Dividend Dates

Complete history of 1 dividend payments by Oramed Pharmaceuticals Inc since 2026. Each row shows the ex-dividend date, amount per share, record date, pay date, and declaration date.

Oramed Pharmaceuticals Inc (XTAE:ORMP) Dividend History
Ex-Dividend Date	Amount	Record Date	Pay Date	Declaration Date
2026-01-15	USD 0.25	2026-01-16	2026-01-26	2026-01-07

Frequently Asked Questions: XTAE:ORMP Dividend

What is Oramed Pharmaceuticals Inc's (XTAE:ORMP) current dividend yield?

Oramed Pharmaceuticals Inc (XTAE:ORMP) currently has a dividend yield of 5.81%, paying $0.25 per share annually. The forward yield is 5.81%.

What is Oramed Pharmaceuticals Inc's payout ratio?

Oramed Pharmaceuticals Inc's payout ratio is 0.14, which represents the percentage of earnings paid out as dividends. A lower payout ratio generally suggests more room for future dividend growth and greater safety during earnings downturns.

How long has Oramed Pharmaceuticals Inc been paying dividends?

Oramed Pharmaceuticals Inc has been paying dividends since 2026, a 0-year track record.

Is Oramed Pharmaceuticals Inc's dividend growing?

Oramed Pharmaceuticals Inc's dividend has grown at an annualized rate of 0% over the past 5 years and 0% over the past 10 years. Dividend growth has been flat or negative recently.

Where can I see Oramed Pharmaceuticals Inc's complete dividend data?

Above this section you'll find Oramed Pharmaceuticals Inc's complete dividend payment history, ex-dividend dates, payout ratio trends, and yield charts. For broader analysis of Oramed Pharmaceuticals Inc as an investment, visit the Oramed Pharmaceuticals Inc Stock summary page on GuruFocus.

Also check out

High Yield Dividend Stocks in Gurus' Portfolio

Top dividend stocks of Warren Buffett

Top dividend stocks of George Soros

All-in-one Screener

Screen For High Dividend Stocks

Dividend Yield History

This is the historical trailing annual dividend yield of Oramed Pharmaceuticals Inc. Buying stocks at higher yield relative its historical values is usually more profitable.

Dividend Per Share History

This the dividend history of Oramed Pharmaceuticals Inc

Dividend Payout Ratio

This is the historical payout ratio of Oramed Pharmaceuticals Inc. If the dividend payout ratio is close to or higher than 1, dividends might not be sustainable.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.